English
Insider transactions
EDGARX4 PHARMACEUTICALS, INC
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 1 transactions, 4,600 shares
- Sum of shares × price per share: 11,883.64
- Open-market sales (code S)
- 5 transactions, 109,283 shares
- Sum of shares × price per share: 462,964.2245
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–11 of 11
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-16 Filed 2026-10-19 | Craig Adam R Director · Officer: Executive Chairman | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 4,600 | 2.5834 | 11,883.64Derived: shares × price per share. Exact value 11883.6400. | 333,251 | Direct (D) | No | F1, F2
| Open filing 0001339498-26-000005 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-05 | KIRSKE DAVID Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 11,767 | 2.8604 | 33,658.3268Derived: shares × price per share. Exact value 33658.3268. | 155,983 | Direct (D) | No | F1, F2, F3
| Open filing 0001501697-26-000078 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-13 | Craig Adam R Director · Officer: Executive Chairman | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 47,436 | 4.4445 | 210,829.302Derived: shares × price per share. Exact value 210829.3020. | 328,651 | Direct (D) | No | F1, F2, F3
| Open filing 0001501697-26-000069 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-13 | Volpone John Officer: President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 24,576 | 4.4445 | 109,228.032Derived: shares × price per share. Exact value 109228.0320. | 265,305 | Direct (D) | No | F1, F2, F3
| Open filing 0001501697-26-000070 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-01 | Gold Kelly Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 110,000 | 0 | — | 110,000 | Direct (D) | No | F1
| Open filing 0001501697-26-000064 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-01 | KIRSKE DAVID Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,543 | 4.2641 | 36,428.2063Derived: shares × price per share. Exact value 36428.2063. | 167,750 | Direct (D) | No | F1, F2, F3
| Open filing 0001501697-26-000065 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-13 | KIRSKE DAVID Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 16,961 | 4.2934 | 72,820.3574Derived: shares × price per share. Exact value 72820.3574. | 176,293 | Direct (D) | No | F1, F2, F3
| Open filing 0001501697-26-000049 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-07 | Bridger Gary Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 110,000 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001501697-26-000009 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-05 | WYZGA MICHAEL S Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 110,000 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001501697-26-000006 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-05 | Stewart Murray Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 110,000 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001501697-26-000005 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-05 | de Craecker Francoise Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 110,000 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001501697-26-000007 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.
Showing 1–50 of 100
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| MORGAN STANLEY Partly reported under another manager | 10,996,210 SH | 31,889,010 dollars | Higher by 1,534,931 Prior quarter: 9,461,279 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Empery Asset Management, LP | 9,725,509 SH | 28,203,976 dollars | Higher by 2,794,918 Prior quarter: 6,930,591 | Open filing 0000919574-26-008014 Filed 2026-11-16 Dispute this row |
| Bain Capital Life Sciences Investors, LLC | 7,967,454 SH | 23,105,616 dollars | Unchanged Prior quarter: 7,967,454 | Open filing 0001193125-26-462089 Filed 2026-11-16 Dispute this row |
| Venrock Adviser, LLC | 7,644,072 SH | 22,167,809 dollars | Higher by 5,709,819 Prior quarter: 1,934,253 | Open filing 0001615982-26-000019 Filed 2026-11-16 Dispute this row |
| Saturn V Capital Management LP | 7,366,442 SH | 21,362,682 dollars | Higher by 393,099 Prior quarter: 6,973,343 | Open filing 0001964437-26-000015 Filed 2026-11-16 Dispute this row |
| PERCEPTIVE ADVISORS LLC | 7,350,491 SH | 21,316,424 dollars | Lower by 583,000 Prior quarter: 7,933,491 | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 5,854,521 SH | 16,978,112 dollars | Higher by 299,615 Prior quarter: 5,554,906 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| FMR LLC Partly reported under another manager | 5,490,787 SH | 15,923,283 dollars | Lower by 2,830,870 Prior quarter: 8,321,657 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| Deep Track Capital, LP | 4,501,684 SH | 13,054,884 dollars | Lower by 1,377,073 Prior quarter: 5,878,757 | Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row |
| Kalehua Capital Management LLC | 3,722,840 SH | 10,796,236 dollars | Lower by 3,722,840 Prior quarter: 7,445,680 | Open filing 0002106181-26-000010 Filed 2026-11-13 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,558,591 SH | 10,319,914 dollars | Lower by 157,268 Prior quarter: 3,715,859 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| Rosalind Advisors, Inc. | 3,214,766 SH | 9,322,821 dollars | Unchanged Prior quarter: 3,214,766 | Open filing 0001622627-26-000034 Filed 2026-11-16 Dispute this row |
| Trails Edge Capital Partners, LP | 2,571,478 SH | 7,457,287 dollars | Unchanged Prior quarter: 2,571,478 | Open filing 0002077247-26-000005 Filed 2026-11-16 Dispute this row |
| Nantahala Capital Management, LLC | 2,449,468 SH | 7,103,457 dollars | Lower by 2,449,468 Prior quarter: 4,898,936 | Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row |
| Blackstone Inc. Partly reported under another manager | 2,427,080 SH | 7,038,532 dollars | Lower by 254,842 Prior quarter: 2,681,922 | Open filing 0001193125-26-463513 Filed 2026-11-16 Dispute this row |
| BRAIDWELL LP | 2,344,822 SH | 6,799,984 dollars | Lower by 577,932 Prior quarter: 2,922,754 | Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 2,335,042 SH | 6,771,622 dollars | Higher by 1,418,506 Prior quarter: 916,536 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Affinity Asset Advisors, LLC | 2,062,500 SH | 5,981,250 dollars | Higher by 1,917,500 Prior quarter: 145,000 | Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 2,047,281 SH | 5,938,800 dollars | Lower by 50,766 Prior quarter: 2,098,047 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 1,730,123 SH | 5,017,357 dollars | Higher by 434,106 Prior quarter: 1,296,017 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| BVF INC/IL Partly reported under another manager | 1,576,624 SH | 4,572,210 dollars | Lower by 657,118 Prior quarter: 2,233,742 | Open filing 0000921895-26-003162 Filed 2026-11-16 Dispute this row |
| SAMSARA BIOCAPITAL, LLC | 1,347,723 SH | 3,908,397 dollars | Lower by 47,864 Prior quarter: 1,395,587 | Open filing 0001744967-26-000014 Filed 2026-11-16 Dispute this row |
| Woodline Partners LP | 1,001,095 SH | 2,903,176 dollars | Unchanged Prior quarter: 1,001,095 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 627,744 SH | 1,820,458 dollars | Lower by 25,105 Prior quarter: 652,849 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 572,106 SH | 1,659,107 dollars | Higher by 29,978 Prior quarter: 542,128 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 512,811 SH | 1,487,152 dollars | Lower by 59,227 Prior quarter: 572,038 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Verdad Advisers, LP | 323,166 SH | 937,181 dollars | Lower by 28,927 Prior quarter: 352,093 | Open filing 0001420506-26-002833 Filed 2026-11-16 Dispute this row |
| WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager | 289,231 SH | 838,770 dollars | Higher by 237,431 Prior quarter: 51,800 | Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 263,282 SH | 763,518 dollars | Higher by 18 Prior quarter: 263,264 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| Caption Management, LLC Option: Call | 250,000 SH | 725,000 dollars | Unchanged Prior quarter: 250,000 | Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row |
| Integral Health Asset Management, LLC | 250,000 SH | 725,000 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005192 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 241,500 SH | 700,350 dollars | Lower by 8,800 Prior quarter: 250,300 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| AMERICAN CENTURY COMPANIES INC Partly reported under another manager | 227,472 SH | 659,668 dollars | Higher by 152,677 Prior quarter: 74,795 | Open filing 0000748054-26-000009 Filed 2026-11-20 Dispute this row |
| Russell Investments Group, Ltd. Partly reported under another manager | 213,258 SH | 618,447 dollars | Higher by 206,080 Prior quarter: 7,178 | Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 204,991 SH | 594,474 dollars | Higher by 8,651 Prior quarter: 196,340 | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 150,205 SH | 435,595 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Stonepine Capital Management, LLC | 150,000 SH | 435,000 dollars | Lower by 74,989 Prior quarter: 224,989 | Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row |
| ALPS ADVISORS INC | 130,424 SH | 378,230 dollars | Higher by 34,698 Prior quarter: 95,726 | Open filing 0001398344-26-019318 Filed 2026-11-03 Dispute this row |
| Invesco Ltd. Partly reported under another manager | 117,230 SH | 339,967 dollars | Higher by 20,458 Prior quarter: 96,772 | Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row |
| RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager | 115,524 SH | 335,020 dollars | Higher by 97,424 Prior quarter: 18,100 | Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 111,057 SH | 322,065 dollars | Higher by 3,668 Prior quarter: 107,389 | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| PRUDENTIAL FINANCIAL INC Partly reported under another manager | 109,705 SH | 318,145 dollars | Higher by 97,205 Prior quarter: 12,500 | Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row |
| Susquehanna Portfolio Strategies, LLC | 102,223 SH | 296,447 dollars | Higher by 14,941 Prior quarter: 87,282 | Open filing 0001996449-26-000009 Filed 2026-11-16 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 100,745 SH | 292,161 dollars | Not in the prior quarter’s filings read | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| RHUMBLINE ADVISERS | 94,984 SH | 275,447 dollars | Lower by 97 Prior quarter: 95,081 | Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row |
| Point72 Asset Management, L.P. | 93,565 SH | 271,339 dollars | Higher by 52,493 Prior quarter: 41,072 | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 83,488 SH | 242,115 dollars | Higher by 16,410 Prior quarter: 67,078 | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 70,237 SH | 203,688 dollars | Higher by 23,376 Prior quarter: 46,861 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| EntryPoint Capital, LLC | 70,147 SH | 203,426 dollars | Not in the prior quarter’s filings read | Open filing 0001992519-26-000009 Filed 2026-11-13 Dispute this row |
| DEUTSCHE BANK AG\ Partly reported under another manager | 68,976 SH | 200,030 dollars | Lower by 9,909 Prior quarter: 78,885 | Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Sixth Street Partners Management Company, L.P. 263,264 SH
- GSA CAPITAL PARTNERS LLP 76,314 SH
- Jump Financial, LLC 34,253 SH
- AXQ CAPITAL, LP 22,880 SH
- INTECH INVESTMENT MANAGEMENT LLC 17,290 SH
- Indivisible Partners 10,000 SH
- JONES FINANCIAL COMPANIES LLLP 38 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.001 par value per share | 7.6 | 7,644,072.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000100 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, $0.001 par value per share | 7.6 | 7,644,072.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000100 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.001 par value per share | 7.6 | 7,644,072.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000100 Dispute this row |
| VHCP Management III, LLC Common Stock, $0.001 par value per share | 7.6 | 7,644,072.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000100 Dispute this row |
| VHCP Management EG, LLC Common Stock, $0.001 par value per share | 7.6 | 7,644,072.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000100 Dispute this row |
| Nimish Shah Common Stock, $0.001 par value per share | 7.6 | 7,644,072.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000100 Dispute this row |
| Bong Y. Koh Common Stock, $0.001 par value per share | 7.6 | 7,644,072.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000100 Dispute this row |
| Deep Track Capital, LP Common Stock, par value $0.001 per share | 6.58 | 6,663,821.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-005081 Dispute this row |
| Deep Track Biotechnology Master Fund, Ltd. Common Stock, par value $0.001 per share | 5.66 | 5,737,941.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-005081 Dispute this row |
| David Kroin Common Stock, par value $0.001 per share | 6.58 | 6,663,821.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-005081 Dispute this row |
| Deep Track Special Opportunities Fund, LP. Common Stock, par value $0.001 per share | 0.91 | 925,880.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-005081 Dispute this row |
| Coastlands Capital LP Common Stock, par value $0.001 per share | 9.99 | 10,719,139.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127412 Dispute this row |
| Coastlands Capital Partners LP Common Stock, par value $0.001 per share | 9.99 | 10,719,139.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127412 Dispute this row |
| Coastlands Capital GP LLC Common Stock, par value $0.001 per share | 9.99 | 10,719,139.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127412 Dispute this row |
| Coastlands Capital LLC Common Stock, par value $0.001 per share | 9.99 | 10,719,139.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127412 Dispute this row |
| Matthew D. Perry Common Stock, par value $0.001 per share | 9.99 | 10,719,139.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127412 Dispute this row |
| FMR LLC COMMON STOCK | 4.6 | 4,558,616.00 | 09/30/2026 Filed 2026-10-07 | SCHEDULE 13G/AAmendment 2 | Open filing 0000315066-26-002326 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 4.6 | 4,558,616.00 | 09/30/2026 Filed 2026-10-07 | SCHEDULE 13G/AAmendment 2 | Open filing 0000315066-26-002326 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.001 par value per share | 5.6 | 5,555,047.00 | 09/14/2026 Filed 2026-09-21 | SCHEDULE 13G | Open filing 0001738048-26-000071 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, $0.001 par value per share | 5.6 | 5,555,047.00 | 09/14/2026 Filed 2026-09-21 | SCHEDULE 13G | Open filing 0001738048-26-000071 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.001 par value per share | 5.6 | 5,555,047.00 | 09/14/2026 Filed 2026-09-21 | SCHEDULE 13G | Open filing 0001738048-26-000071 Dispute this row |
| VHCP Management III, LLC Common Stock, $0.001 par value per share | 5.6 | 5,555,047.00 | 09/14/2026 Filed 2026-09-21 | SCHEDULE 13G | Open filing 0001738048-26-000071 Dispute this row |
| VHCP Management EG, LLC Common Stock, $0.001 par value per share | 5.6 | 5,555,047.00 | 09/14/2026 Filed 2026-09-21 | SCHEDULE 13G | Open filing 0001738048-26-000071 Dispute this row |
| Nimish Shah Common Stock, $0.001 par value per share | 5.6 | 5,555,047.00 | 09/14/2026 Filed 2026-09-21 | SCHEDULE 13G | Open filing 0001738048-26-000071 Dispute this row |
| Bong Y. Koh Common Stock, $0.001 par value per share | 5.6 | 5,555,047.00 | 09/14/2026 Filed 2026-09-21 | SCHEDULE 13G | Open filing 0001738048-26-000071 Dispute this row |
| Perceptive Advisors LLC Common Stock, par value $0.001 per share | 8.1 | 8,085,006 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-352651 Dispute this row |
| Joseph Edelman Common Stock, par value $0.001 per share | 8.1 | 8,085,006 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-352651 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.001 per share | 8.1 | 8,085,006 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-352651 Dispute this row |
| Deep Track Capital, LP Common Stock, par value $0.001 per share | 8.33 | 8,040,894.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-003487 Dispute this row |
| Deep Track Biotechnology Master Fund, Ltd. Common Stock, par value $0.001 per share | 7.18 | 6,923,680.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-003487 Dispute this row |
| David Kroin Common Stock, par value $0.001 per share | 8.33 | 8,040,894.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-003487 Dispute this row |
| Deep Track Special Opportunities Fund, LP. Common Stock, par value $0.001 per share | 1.16 | 1,117,214.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-003487 Dispute this row |
| BlackRock, Inc. Common Stock | 5.9 | 5,529,573 | 06/30/2026 Filed 2026-07-30 | SCHEDULE 13G | Open filing 0002012383-26-003133 Dispute this row |
| Perceptive Advisors LLC Common Stock, par value $0.001 per share | 7.3 | 6,889,163 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-226568 Dispute this row |
| Joseph Edelman Common Stock, par value $0.001 per share | 7.3 | 6,889,163 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-226568 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.001 per share | 7.3 | 6,889,163 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-226568 Dispute this row |
| Morgan Stanley Common Stock | 10.2 | 8,884,338 | 02/28/2026 Filed 2026-03-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0000895421-26-000094 Dispute this row |
| Morgan Stanley Investment Management Inc. Common Stock | 10.2 | 8,884,304 | 02/28/2026 Filed 2026-03-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0000895421-26-000094 Dispute this row |
| Inception Trust Common Stock | 5.2 | 4,518,236 | 02/28/2026 Filed 2026-03-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0000895421-26-000094 Dispute this row |
| Bain Capital Life Sciences Fund, L.P. Common Stock, par value $0.001 per share | 0 | 0 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-054779 Dispute this row |
| Bain Capital Life Sciences Fund II, L.P. Common Stock, par value $0.001 per share | 0.07 | 64,190 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-054779 Dispute this row |
| BCIP Life Sciences Associates, LP Common Stock, par value $0.001 per share | 0.01 | 7,817 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-054779 Dispute this row |
| BCLS II Investco, LP Common Stock, par value $0.001 per share | 0.8 | 758,598 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-054779 Dispute this row |
| BCLS I Investco, LP Common Stock, par value $0.001 per share | 0.09 | 89,633 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-054779 Dispute this row |
| BCLS II Equity Opportunities, LP Common Stock, par value $0.001 per share | 7.43 | 7,047,216 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-054779 Dispute this row |
| Trails Edge Capital Partners, LP Common Stock, par value $0.001 per share | 5.8 | 5,227,222.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-007144 Dispute this row |
| Trails Edge Biotechnology Master Fund, LP Common Stock, par value $0.001 per share | 5.8 | 5,227,222.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-007144 Dispute this row |
| Ortav Yehudai Common Stock, par value $0.001 per share | 5.8 | 5,227,222.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-007144 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, par value $0.001 per share | 2.1 | 1,827,005.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000476 Dispute this row |
| BVF I GP LLC Common Stock, par value $0.001 per share | 2.1 | 1,827,005.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000476 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,708,462 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 124,844 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.